‘The 940nm diode laser beam was found to possess higher efficacy for deeper blood vessels based upon its excellent penetration of the dermis with a longer wavelength. Furthermore, the 940nm wavelength corresponds with a lesser absorption peak of oxyhemoglobin than that for 532 nm, resulting in slower and even more uniform heating system of the vessel,’ said lead writer Emily Tierney, MD, an associate professor of dermatology at BUSM. ‘In addition, there is usually minimal melanin absorption at the 940nm wavelength, and therefore, there is less risk of post-inflammatory transformation or scarring,’ she added.He’s scientific insights on genotyping research design,’ said Jay Kaufman, Vice President of DNA Item Marketing at Affymetrix. ‘Our clients in China, including Dr. He and Dr. Yong Yong Shi, who operate the largest genotyping laboratory in China, needed more focused, Chinese-specific content material to give them better genetic coverage and more power thus. The Chinese myDesign Genotyping Array meets these needs.’ The array is normally in development and will be commercialized later on this year for other researchers thinking about leveraging this powerful research tool. ‘Affymetrix customers are in the forefront in an ever-changing field of genotyping research, in fact it is our mission to continue providing the genetic data and microarray technology that may maintain them at the leading edge of human disease research,’ stated Affymetrix CEO and President Kevin King.